DrugNews Adds December Yaz Birth Control Lawsuit Updates

http://www.DrugNews.net is the web’s premier source for prescription device warnings, research, side effects and legal news. Visit the DrugNews Center today.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
yaz lawsuit
The resource center has added warnings from health experts like the British Medical Journal and FDA that birth control pills containing the hormone drospirenone, such as Yaz and Yasmin, can increase the risk of blood clots.

Chicago, IL (PRWEB) December 20, 2013

The birth control safety advocates at DrugNews.net have added updated information for women who took the contraceptives Yaz or Yasmin. New court records show lawsuits alleging the drug caused side effects have dropped slightly as thousands have received settlements*.

DrugNews is a free resource for those taking popular prescription drugs, providing the latest safety alerts, recalls, studies and legal news. Patients can avoid potential dangers, see if others are experiencing similar side effects and decide if they need legal advice.

The resource center has added warnings from health experts like the British Medical Journal** and FDA*** that birth control pills containing the hormone drospirenone, such as Yaz and Yasmin, can increase the risk of blood clots.

Thousands of women have already filed a Yaz lawsuit alleging side effects, leading to the consolidation of cases to a special federal Multi-District Litigation court. (Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois)).

The resource center has added information showing Bayer, the maker of Yaz, has already spent around $1.575 billion to settle approximately 7,660 Yaz lawsuits alleging blood clot injuries like pulmonary embolism or deep vein thrombosis (DVT)****.

Now, DrugNews has learned the latest court records show the number of Yaz claims still pending has dropped slightly from 9,837 on November 18th to 9,826 as of December 16*.

Anyone who suffered a blood clot, DVT, stroke or pulmonary embolism after taking Yaz or Yasmin is urged to contact the DrugNews Center or speak with a lawyer about their options under the current settlement.

Due to the complexity of drug injury cases, patients should seek a lawyer with experience in defective drug litigation. DrugNews only recommends lawyers who have already settled Yaz lawsuits.

For more information on the research, side effects and litigation news related to Yaz and other drugs, or to speak with a lawyer, visit http://www.DrugNews.net.

*JPML 12/16/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-December-16-2013.pdf
**BMJ, 10/25/11; ncbi.nlm.nih.gov/pubmed/22027398
***FDA, 10/27/11, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf
****Bayer Stockholder’s Newsletter, Explanatory Notes; Legal Risks, 10/31/13; stockholders-newsletter-q3-2013.bayer.com/en/explanatory-notes.aspx


Contact